BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37545936)

  • 1. Predictors of mortality and survival probability distribution among patients on tuberculosis treatment in Vihiga County, Kenya.
    Wekunda PW; Aduda DSO; Guyah B; Odongo J
    Afr Health Sci; 2023 Mar; 23(1):218-230. PubMed ID: 37545936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of tuberculosis treatment interruption among patients in Vihiga County, Kenya.
    Wekunda PW; Aduda DSO; Guyah B
    PLoS One; 2021; 16(12):e0260669. PubMed ID: 34855844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival model analysis of tuberculosis treatment among patients with human immunodeficiency virus coinfection.
    Azeez A; Mutambayi R; Odeyemi A; Ndege J
    Int J Mycobacteriol; 2019; 8(3):244-251. PubMed ID: 31512600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burden of HIV and treatment outcomes among TB patients in rural Kenya: a 9-year longitudinal study.
    Ngari MM; Rashid MA; Sanga D; Mathenge H; Agoro O; Mberia JK; Katana GG; Vaillant M; Abdullahi OA
    BMC Infect Dis; 2023 May; 23(1):362. PubMed ID: 37254064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of mortality in adults on treatment for human immunodeficiency virus-associated tuberculosis in Botswana: A retrospective cohort study.
    Muyaya LM; Young T; Loveday M
    Medicine (Baltimore); 2018 Apr; 97(16):e0486. PubMed ID: 29668628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for excess mortality and death in adults with tuberculosis in Western Kenya.
    van't Hoog AH; Williamson J; Sewe M; Mboya P; Odeny LO; Agaya JA; Amolloh M; Borgdorff MW; Laserson KF
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1649-56. PubMed ID: 23131264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.
    Assebe LF; Reda HL; Wubeneh AD; Lerebo WT; Lambert SM
    BMC Public Health; 2015 Apr; 15():346. PubMed ID: 25886730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya.
    Abdullahi OA; Ngari MM; Sanga D; Katana G; Willetts A
    PLoS One; 2019; 14(7):e0219191. PubMed ID: 31295277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associated factors with unsuccessful tuberculosis treatment outcomes among tuberculosis/HIV coinfected patients with drug-resistant tuberculosis.
    Azeez A; Ndege J; Mutambayi R
    Int J Mycobacteriol; 2018; 7(4):347-354. PubMed ID: 30531033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, Mekelle, Ethiopia, 2009-2016: survival model approach.
    Gezae KE; Abebe HT; Gebretsadik LG
    BMC Infect Dis; 2019 Feb; 19(1):107. PubMed ID: 30717705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinant factors for mortality during treatment among tuberculosis patients: Cox proportional hazards model.
    Abedi S; Moosazadeh M; Afshari M; Charati JY; Nezammahalleh A
    Indian J Tuberc; 2019 Jan; 66(1):39-43. PubMed ID: 30797281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of death among TB/HIV co-infected patients on tuberculosis treatment in Sichuan, China: A retrospective cohort study.
    Yang N; He J; Li J; Zhong Y; Song Y; Chen C
    Medicine (Baltimore); 2023 Feb; 102(5):e32811. PubMed ID: 36749231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
    Atalell KA; Birhan Tebeje N; Ekubagewargies DT
    PLoS One; 2018; 13(5):e0197145. PubMed ID: 29787596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality among tuberculosis patients in the Democratic Republic of Congo.
    Henegar C; Behets F; Vanden Driessche K; Tabala M; Bahati E; Bola V; Van Rie A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1199-204. PubMed ID: 22871326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and determinants of tuberculosis infection among adult patients with HIV attending HIV care in north-east Ethiopia: a retrospective cohort study.
    Ahmed A; Mekonnen D; Shiferaw AM; Belayneh F; Yenit MK
    BMJ Open; 2018 Feb; 8(2):e016961. PubMed ID: 29437750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution patterns of drug resistance Mycobacterium tuberculosis among HIV negative and positive tuberculosis patients in Western Kenya.
    Ogwang MO; Imbuga M; Ngugi C; Mutharia L; Magoma G; Diero L
    BMC Infect Dis; 2021 Nov; 21(1):1175. PubMed ID: 34809602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and determinants of tuberculosis among HIV-positive individuals in Addis Ababa, Ethiopia: A retrospective cohort study.
    Alemu A; Yesuf A; Zerihun B; Getu M; Worku T; Bitew ZW
    Int J Infect Dis; 2020 Jun; 95():59-66. PubMed ID: 32126324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy.
    Worodria W; Massinga-Loembe M; Mazakpwe D; Luzinda K; Menten J; Van Leth F; Mayanja-Kizza H; Kestens L; Mugerwa RD; Reiss P; Colebunders R;
    J Acquir Immune Defic Syndr; 2011 Sep; 58(1):32-7. PubMed ID: 21654499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new health care index predicts short term mortality for TB and HIV co-infected people.
    Roen AO; Podlekareva D; Miller RF; Mocroft A; Panteleev A; Skrahina A; Miro JM; Cayla JA; Tetradov S; Derisova E; Furrer H; Losso MH; Vassilenko A; Girardi E; Lundgren JD; Post FA; Kirk O
    Int J Tuberc Lung Dis; 2020 Sep; 24(9):956-962. PubMed ID: 33156764
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.
    Hafkin J; Modongo C; Newcomb C; Lowenthal E; MacGregor RR; Steenhoff AP; Friedman H; Bisson GP
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):348-53. PubMed ID: 23321297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.